Plain-English translation of NCT06398639 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Prostate Cancer research guide โThis study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This research study is testing a smarter way to screen for prostate cancer by combining two approaches: a genetic test that identifies your personal risk based on your DNA, and an MRI scan that looks for signs of cancer. Instead of screening all men the same way, this strategy aims to focus screening on men who actually need it and spare those at lower risk from unnecessary testing.
Current prostate cancer screening using a blood test called PSA is controversial because it catches many cancers that would never cause harm, leading to unnecessary worry, biopsies, and treatment. This trial exists to develop a more targeted approach that catches only the serious cancers worth treating while avoiding overdiagnosis in men at low risk.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will have a blood test to measure PSA levels and determine your genetic risk score from your DNA. You will also receive an MRI scan of your prostate. Based on your results, you'll be placed into a risk group (low, intermediate, or high), and your follow-up care will be determined by those findings. The study team will follow up with you to see how the screening approach works over time.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
United States